Riskpilot← Back to searchSign inGet full accessEdelhierta AB
ABActiveOrg 5567566103Ulriksdal SlottsfogdebostadenMedical specialists activities · NACE 8622Est. 20081 employees
Revenue 2025
SEK 211K
-2% vs 2024
EBITDA margin
-54.3%
+24% vs 2024
Equity ratio
98.7%
Financial strength
Net profit 2025
SEK 521K
+53% vs 2024
| Revenue | SEK 211K | -2% |
| EBITDA | SEK -114K | +24% |
| Net profit | SEK 521K | +53% |
| Total assets | SEK 4,6M | +0% |
| Equity | SEK 4,6M | +7% |
| Employees | 1 | — |
Legal name
Edelhierta AB
Org number
5567566103
Legal form
Aktiebolag
NACE code
8622 · Medical specialists activities
Founded
22 april 2008
Share capital
SEK 100 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Föremålet för bolagets verksamhet är medicinsk läkarvård, konsultverksamhet omfattande vård, undervisnings-, forsknings- och utvecklingsverksamhet och därmed annan förenlig verksamhet.
Address
Ulriksdal Slottsfogdebostaden
Phone
+46707794027
Email
marten.rosenqvist@ds.se
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 740 | 670 | 457 | 216 | 211 |
| Staff expenses | — | — | −13 | −15 | −16 |
| EBITDA | 302 | −212 | 74 | −150 | −114 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 302 | −212 | 74 | −150 | −114 |
| Net financials | 191 | 2 750 | 153 | 488 | 527 |
| Profit before tax | 618 | 2 687 | 328 | 436 | 533 |
| Tax | −147 | −55 | −76 | −95 | −12 |
| Net profit | 471 | 2 632 | 252 | 341 | 521 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 2 460 | 4 900 | 4 557 | 4 631 | 4 622 |
| Equity | 1 582 | 4 034 | 4 099 | 4 245 | 4 562 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 410 | 547 | 240 | 266 | 60 |
| Total debt | 410 | 547 | 240 | 266 | 60 |
EBITDA margin
-54.3%
This company
15.8%
Market median
-444% vs market
20212025
Equity ratio
98.7%
This company
38.2%
Market median
+158% vs market
20212025
Return on equity
11.4%
This company
18.4%
Market median
+38% vs market
20212025
Net profit margin
247.1%
This company
8.1%
Market median
+2951% vs market
20212025
Asset turnover
0.05×
This company
1.12×
Market median
-96% vs market
20212025
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
CM | Audit | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Edelhierta AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Camilla Margareta Andersson | Audit | 0 companies |
| Emelie Rosenqvist | Deputy Board Member | 0 companies |
| Mårten Rosenqvist | Board of Directors | 0 companies |